4//SEC Filing
Karydas Daphne 4
Accession 0001209191-21-040427
CIK 0001664106other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 8:00 PM ET
Size
9.2 KB
Accession
0001209191-21-040427
Insider Transaction Report
Form 4
Karydas Daphne
Director
Transactions
- Award
Stock Option (right to buy)
2021-06-11+12,500→ 12,500 totalExercise: $4.59Exp: 2031-06-11→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]The options were granted by the Issuer pursuant to its 2018 Equity Incentive Plan as provided under the Company's compensation policy for non-employee directors. All of the options will vest and become exercisable on the earlier of (i) the first anniversary of the grant date, and (ii) the day prior to the Company's 2022 annual meeting of stockholders, subject to the Reporting Person's continuous service with the Issuer through the vesting date.
Issuer
LogicBio Therapeutics, Inc.
CIK 0001664106
Entity typeother
Related Parties
1- filerCIK 0001816952
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 8:00 PM ET
- Size
- 9.2 KB